Enterocytozoon bieneusi Microsporidiosis in Stem Cell Transplant Recipients Treated with Fumagillin - Université Pierre et Marie Curie Accéder directement au contenu
Article Dans Une Revue Emerging Infectious Diseases Année : 2017

Enterocytozoon bieneusi Microsporidiosis in Stem Cell Transplant Recipients Treated with Fumagillin

Résumé

Enterocytozoon bieneusi microsporidiosis is an emerging disease in immunocompromised patients. We report 2 cases of this disease in allogeneic hematopoietic stem cell transplant patients successfully treated with fumagillin. Thrombocytopenia occurred but without major adverse events. Modifications of immunosuppression could be avoided when E. bieneusi is rapidly identified and fumagillin therapy is started promptly.
Fichier principal
Vignette du fichier
16-1825.pdf (404.19 Ko) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

hal-01541632 , version 1 (19-06-2017)

Licence

Paternité

Identifiants

Citer

Iryna Bukreyeva, Adela Angoulvant, Inès Bendib, Jean-Charles Gagnard, Jean-Henri Bourhis, et al.. Enterocytozoon bieneusi Microsporidiosis in Stem Cell Transplant Recipients Treated with Fumagillin. Emerging Infectious Diseases, 2017, 23 (6), pp.1039-1041. ⟨10.3201/eid2306.161825⟩. ⟨hal-01541632⟩
216 Consultations
221 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More